Literature DB >> 7910662

The management of hyperthyroidism.

J A Franklyn1.   

Abstract

Although effective treatments for hyperthyroidism are available, none is perfect. Particularly with respect to Graves' disease, what is needed is a therapy directed at modulating the disease process itself rather than merely reducing the synthesis and secretion of thyroid hormones in the hope that the underlying Graves' disease will remit. Greater understanding of the pathogenesis of Graves' disease, resulting from cloning of the thyrotropin receptor and better knowledge of the interactions between these receptors or other thyroid antigens and the immune system, may lead to such treatment. Broad-spectrum immunosuppression, with all its side effects, is not the answer; more focused therapies to inhibit the immune response to specific thyroid antigens may represent the treatment of the future. Meanwhile, radioiodine therapy is the most effective and convenient method of achieving long-term control of hyperthyroidism, although at the cost of hypothyroidism in many patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910662     DOI: 10.1056/NEJM199406163302407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  33 in total

1.  Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, its immunological effects must be taken into account.

Authors:  L Chiovato; R Rocchi; E Fiore
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 2.  Diagnosis and management of Graves' disease.

Authors:  Jody Ginsberg
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

3.  Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.

Authors:  Martin A Walter; Matthias Briel; Mirjam Christ-Crain; Steen J Bonnema; John Connell; David S Cooper; Heiner C Bucher; Jan Müller-Brand; Beat Müller
Journal:  BMJ       Date:  2007-02-19

Review 4.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Long-term outcomes of treatment of hyperthyroidism in Ireland.

Authors:  A C Leary; G Grealy; T M Higgins; N Buckley; D G Barry; D Murphy; J B Ferriss
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

6.  Long-term outcome of Graves' disease patients treated in a region with iodine deficiency: relapse rate increases in years with thionamides.

Authors:  Neslihan Basçil Tütüncü; Tanju Tütüncü; Ali Ozgen; Tomris Erbas
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

7.  Results of surgery for toxic multinodular goiter.

Authors:  Antonio Ríos; José M Rodríguez; María D Balsalobre; Nuria M Torregrosa; Francisco J Tebar; Pascual Parrilla
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Current and emerging treatment options for Graves' hyperthyroidism.

Authors:  Prakash Abraham; Shamasunder Acharya
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

Review 9.  Antithyroid drug regimen for treating Graves' hyperthyroidism.

Authors:  Prakash Abraham; Alison Avenell; Susan C McGeoch; Louise F Clark; John S Bevan
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 10.  Juvenile thyrotoxicosis; can we do better?

Authors:  G Birrell; T Cheetham
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.